JP2013506637A5 - - Google Patents

Download PDF

Info

Publication number
JP2013506637A5
JP2013506637A5 JP2012531445A JP2012531445A JP2013506637A5 JP 2013506637 A5 JP2013506637 A5 JP 2013506637A5 JP 2012531445 A JP2012531445 A JP 2012531445A JP 2012531445 A JP2012531445 A JP 2012531445A JP 2013506637 A5 JP2013506637 A5 JP 2013506637A5
Authority
JP
Japan
Prior art keywords
group
carbonyl
carboxamide
pyrrole
following structural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012531445A
Other languages
English (en)
Japanese (ja)
Other versions
JP5746185B2 (ja
JP2013506637A (ja
Filing date
Publication date
Priority claimed from EP09382193A external-priority patent/EP2305643A1/en
Application filed filed Critical
Publication of JP2013506637A publication Critical patent/JP2013506637A/ja
Publication of JP2013506637A5 publication Critical patent/JP2013506637A5/ja
Application granted granted Critical
Publication of JP5746185B2 publication Critical patent/JP5746185B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012531445A 2009-10-02 2010-10-01 三置換1h−ピロール類と、芳香族スペーサーおよびヘテロ芳香族スペーサーとに同時に基づく新規ヒストンデアセチラーゼ阻害剤 Active JP5746185B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09382193.2 2009-10-02
EP09382193A EP2305643A1 (en) 2009-10-02 2009-10-02 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
PCT/EP2010/064653 WO2011039353A1 (en) 2009-10-02 2010-10-01 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers

Publications (3)

Publication Number Publication Date
JP2013506637A JP2013506637A (ja) 2013-02-28
JP2013506637A5 true JP2013506637A5 (enExample) 2013-11-07
JP5746185B2 JP5746185B2 (ja) 2015-07-08

Family

ID=41716282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012531445A Active JP5746185B2 (ja) 2009-10-02 2010-10-01 三置換1h−ピロール類と、芳香族スペーサーおよびヘテロ芳香族スペーサーとに同時に基づく新規ヒストンデアセチラーゼ阻害剤

Country Status (16)

Country Link
US (1) US8685992B2 (enExample)
EP (2) EP2305643A1 (enExample)
JP (1) JP5746185B2 (enExample)
KR (1) KR101754940B1 (enExample)
CN (1) CN102648177B (enExample)
AU (1) AU2010302572B2 (enExample)
BR (1) BR112012007411B8 (enExample)
CA (1) CA2776351C (enExample)
ES (1) ES2452868T3 (enExample)
IL (1) IL218995A (enExample)
IN (1) IN2012DN03129A (enExample)
MX (1) MX2012003988A (enExample)
PL (1) PL2483242T3 (enExample)
PT (1) PT2483242E (enExample)
RU (1) RU2549885C2 (enExample)
WO (1) WO2011039353A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103327972A (zh) * 2010-10-11 2013-09-25 里兰斯坦福初级大学理事会 取代的苯甲酰胺及其用途
EP2991982B1 (en) 2013-04-29 2018-08-15 Chong Kun Dang Pharmaceutical Corp. Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
US10239845B2 (en) 2015-02-02 2019-03-26 Forma Therapeutics, Inc. 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US10183934B2 (en) 2015-02-02 2019-01-22 Forma Therapeutics, Inc. Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
WO2017029684A1 (en) * 2015-08-17 2017-02-23 University Of Mysore 2,3,5 trisubstituted pyrrole derivatives as topoisomerase inhibitors and therapeutic uses thereof
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
CN107793375A (zh) * 2016-08-31 2018-03-13 中国科学院上海药物研究所 一类芳基2,2’‑串联双噻唑类化合物及其制备方法和用途
EP3318256A1 (en) * 2016-11-08 2018-05-09 Quimatryx, S.L Compounds for the treatment of autoimmune diseases
GB201708457D0 (en) * 2017-05-26 2017-07-12 Univ Oxford Innovation Ltd Inhibitors of metallo-beta-lactamases
CN110938055A (zh) * 2018-09-21 2020-03-31 华东师范大学 六元环甲酰胺类化合物及其合成方法和应用
WO2020212479A1 (en) 2019-04-17 2020-10-22 Quimatryx, S.L. 1,3,4-oxadiazole derivatives as histone deacetylase inhibitors
CN112516142B (zh) * 2020-12-11 2021-10-15 北京华氏精恒医药科技有限公司 一种具有hdac抑制活性的药物组合物、制备方法及其用途
CN112225737B (zh) * 2020-12-11 2021-04-09 北京鑫开元医药科技有限公司 具有hdac抑制活性的化合物、制备方法、组合物及用途
CN116813560A (zh) * 2022-03-28 2023-09-29 上海科技大学 三唑酰胺类化合物及其制备方法和用途
CN114558004B (zh) * 2022-03-29 2023-08-11 奎马特里克斯有限公司 Qtx125药物制剂
CN114634489B (zh) * 2022-04-19 2023-07-04 奎马特里克斯有限公司 结晶形式
CN114652715B (zh) * 2022-04-29 2023-04-25 奎马特里克斯有限公司 联合疗法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA76977C2 (en) * 2001-03-02 2006-10-16 Icos Corp Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
TWI349664B (en) 2003-09-22 2011-10-01 S Bio Pte Ltd Benzimidazole derivatives: preparation and pharmaceutical applications
EP1691803A1 (en) * 2003-12-05 2006-08-23 Warner-Lambert Company LLC N-alkyl pyrroles as hmg-coa reductase inhibitors
US20090298905A1 (en) * 2005-04-15 2009-12-03 Fernando Pedro Cossio Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof
US7754717B2 (en) * 2005-08-15 2010-07-13 Amgen Inc. Bis-aryl amide compounds and methods of use
RU2416600C2 (ru) * 2005-12-27 2011-04-20 Универсидад Дель Паис Васко-Еускал Еррико Унибертситатеа (Упв-Ееу) Новые производные пиррола с ингибирующей гистондеацетилазу активностью
EP2217588A4 (en) * 2007-11-02 2013-12-04 Methylgene Inc INHIBITORS OF HISTONE DEACETYLASE

Similar Documents

Publication Publication Date Title
JP2013506637A5 (enExample)
RU2012117885A (ru) 2,3,5-тризамещенные пирролы, фармацевтическая композиция и лекарственное средство (варианты) на их основе, способ получения соединений (варианты)
AU2002342607B2 (en) Aminoisoxazole derivatives active as kinase inhibitors
JP6017313B2 (ja) 化合物および方法
RU2462454C2 (ru) Новое сульфонамидное производное малоновой кислоты и его фармацевтическое применение
JP2007523905A5 (enExample)
JP2008509982A5 (enExample)
CA2396824A1 (en) Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
JP2004534035A5 (enExample)
JP2010501587A5 (enExample)
AU2006300422A1 (en) Triarylcarboxylic acid derivative
RU2408589C2 (ru) Соединения и композиции в качестве модуляторов ppar-рецепторов, активируемых пролифератором пероксисом
JP2010540462A5 (enExample)
JPH11193281A (ja) アデノシンa3受容体拮抗剤およびチアゾール化合物
RU2010120682A (ru) Ингибиторы гистондезацетилазы
JP2004521908A5 (enExample)
JP2005527625A5 (enExample)
RU2005124359A (ru) Пирролилтиазолы и их применение в качестве обратных агонистов рецептора св 1
NZ589504A (en) Substituted carbinol compound having cyclic linker
JP2011500679A5 (enExample)
JP2005514432A5 (enExample)
JP2009517368A5 (enExample)
JP2005504725A5 (enExample)
RU2008125433A (ru) (r)-арилалкиламинопроизводные и содержащие их фармацевтические композиции
JP2009514866A5 (enExample)